BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Med’s Industry

66 Percent of APAC Patients Face Specialist Delays as Philips Urges Trust in AI to Ease Healthcare Pressures

66% of patients surveyed in APAC are experiencing delays in seeing specialist doctor, with an average waiting time of 47 days 89% of healt...

June 13, 2025 | Report

DKSH Expands Healthcare Distribution Centre in Brunei to Strengthen National Supply Chain

DKSH has officially launched its newly expanded distribution center in Brunei, strengthening its capabilities to support the growth and resilience of the n...

June 13, 2025 | News

Gene Solutions Partners with Topgen to Expand Advanced Cancer Genomics Across 1,300+ Chinese Hospitals

Gene Solutions has formalized a strategic collaboration with Zhejiang Shaoxing Topgen Biomedical Technology Co., Ltd., a CAP...

June 13, 2025 | News

Deep Apple Therapeutics and Novo Nordisk Join Forces to Develop Next-Gen Oral Therapies for Cardiometabolic Diseases

- Deep Apple Therapeutics Announces Collaboration with Novo Nordisk to Discover and Develop Oral Therapies for Cardiometabolic Diseases The partnership ai...

June 12, 2025 | News

ClavystBio and A*STAR Join Forces to Accelerate MedTech Venture Creation and Commercialisation in Singapore

ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), S...

June 11, 2025 | News

Harrow Secures Exclusive U.S. Rights to BYQLOVI for Post-Surgical Eye Care Following FDA Approval

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW), today a...

June 10, 2025 | News

VivaVision Receives Positive FDA Feedback on VVN461LD Phase 2 Trial for Ocular Inflammation

VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced today t...

June 10, 2025 | News

YolTech Therapeutics Receives FDA IND Clearance for In Vivo Base Editing Therapy YOLT-101

YolTech Therapeutics, a clinical-stage biotechnology company developing in vivo genome editing therapies, announced that the U.S. Food and Drug ...

June 09, 2025 | News

Pantai Hospital Kuala Lumpur Achieves Landmark Minimally Invasive Cardiac Procedure

Pantai Hospital Kuala Lumpur (PHKL) marked a significant milestone in cardiovascular care with the successful transcatheter device occlusion of a patent du...

June 06, 2025 | News

Innovent and HUTCHMED’s Sintilimab-Fruquintinib Combo Accepted for NMPA Review in Advanced Renal Cell Carcinoma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

June 05, 2025 | News

Continuity Biosciences Acquires Focal Medical to Advance Site-Specific Chemotherapy for Pancreatic Cancer

Continuity Biosciences, LLC, a developer of advanced drug delivery technologies, announced the acquisition of Focal Medical, Inc., a North Carol...

June 05, 2025 | News

Innovent Secures Second NMPA Breakthrough Therapy Designation for IBI363 in Advanced Lung Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...

June 05, 2025 | News

Concord Healthcare Unveils China’s First Proton Therapy-Focused Large Language Model

Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), whic...

June 02, 2025 | News

CirCode Secures FDA IND Clearance for World’s First Circular RNA Therapy in Ischemic Heart Disease

Shanghai CirCode Biomed Co. Ltd. (CirCode), an innovative biotech company pioneering circular RNA therapies, recently announced that its leading pipeline H...

June 02, 2025 | News

Stay Connected